Literature DB >> 15958209

Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation.

Paloma Valverde1.   

Abstract

The receptor tyrosine kinase Axl has been shown to be activated by its ligand Gas6 and by oxidative stress in the form of hydrogen peroxide. However, the regulatory mechanisms controlling the levels of Axl upon Gas6 binding or oxidative stress have not been elucidated. This report demonstrates that Gas6-induced downregulation of Axl is blocked by inhibitors of endocytosis and lysosomal degradation, but not by inhibitors of proteosomal activity. Furthermore, it is shown that binding of Axl to Gas6 induces the phosphorylation and ubiquitination of Axl and the interaction of Axl with the ubiquitin ligase c-Cbl. Importantly, hydrogen peroxide induces Axl tyrosine phosphorylation but not its ubiquitination, determining the inhibition of Axl downregulation. These results suggest that as shown for other receptor tyrosine kinases, ubiquitination of Axl is needed to ensure its proper degradation in the lysosome, and that oxidative stress may inhibit Axl ubiquitination and downregulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958209     DOI: 10.1016/j.bbrc.2005.05.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.

Authors:  Adil Anwar; Amy K Keating; David Joung; Susan Sather; Grace K Kim; Kelly K Sawczyn; Luis Brandão; Peter M Henson; Douglas K Graham
Journal:  J Leukoc Biol       Date:  2009-04-22       Impact factor: 4.962

2.  Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype.

Authors:  Naoya Fujino; Hiroshi Kubo; Rose A Maciewicz
Journal:  Lab Invest       Date:  2017-05-29       Impact factor: 5.662

3.  Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.

Authors:  Makoto Kuroda; Daisuke Fujikura; Asuka Nanbo; Andrea Marzi; Osamu Noyori; Masahiro Kajihara; Junki Maruyama; Keita Matsuno; Hiroko Miyamoto; Reiko Yoshida; Heinz Feldmann; Ayato Takada
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 4.  Axl-dependent signalling: a clinical update.

Authors:  Vyacheslav A Korshunov
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

5.  Oncogenic pathway driven by p85β: upstream signals to activate p110.

Authors:  Ling Rao; Lydia W T Cheung
Journal:  Mol Cell Oncol       Date:  2020-07-13

6.  The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.

Authors:  Asish K Ghosh; Charla Secreto; Justin Boysen; Traci Sassoon; Tait D Shanafelt; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2010-12-06       Impact factor: 22.113

7.  Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Authors:  Masayuki Shimojima; Ayato Takada; Hideki Ebihara; Gabriele Neumann; Kouki Fujioka; Tatsuro Irimura; Steven Jones; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 8.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 9.  Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy.

Authors:  Maurizio Scaltriti; Moshe Elkabets; José Baselga
Journal:  Clin Cancer Res       Date:  2016-01-13       Impact factor: 12.531

10.  Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.

Authors:  Xianzhou Song; Hironari Akasaka; Hua Wang; Reza Abbasgholizadeh; Ji-Hyun Shin; Fenglin Zang; Jiayi Chen; Craig D Logsdon; Anirban Maitra; Andrew J Bean; Huamin Wang
Journal:  J Biol Chem       Date:  2020-01-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.